Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study

por Sollena, Pietro, Vasiliki, Nikolaou, Kotteas, Elias, Stratigos, Alexander J., Fattore, Davide, Orlandi, Armando, Mannino, Maria, Di Pumpo, Marcello, Fida, Monika, Starace, Michela, Apalla, Zoe, Romano, Maria Concetta, Riganti, Julia, Segura, Sonia, Martinez, Azael Freites, Fabbrocini, Gabriella, Sibaud, Vincent, Peris, Ketty
Publicado 2023